If you need more lookups,
subscriptions start at $34 USD/month.
Hans Christinger Location
New York, NY, US
Hans Christinger Work
2025 -now Chief Business Officer @
2019 -now Director @ NYBIO
2023 -now Founder, CEO @ Modig Life Sciences
2021 -2023 Chief Business Officer @
2019 -2023 Director @
2017 -2021 Vice President, Business Development and Alliance Management @
2015 -2018 Advisory Board Member @
2014 -2017 Vice President, Business Dev. and Alliance Management @
2010 -2014 Director, Business Development, Established Products Division @
2007 -2010 Global Alliance Director @
2003 -2007 Sr. Mgr., Licensing and New Business Development @
2002 -2003 Technology Coordinator @
2001 -2002 Business Development MBA Intern @
1991 -2000 Research Associate @
Hans Christinger Education
Babson College
Master of Business Administration
2000-2002
San Francisco State University
Master of Science (Biochemistry, Chemistry)
1996-1999
Vermont
Bachelor of Science (Biochemistry)
1986-1990
Hans Christinger Skills
Drug Development
Pharmaceutical Industry
Biotechnology
Lifesciences
Drug Delivery
Business Development
Technology Transfer
Biopharmaceuticals
Oncology
Management
Clinical Development
Regulatory Affairs
Therapeutic Areas
Medical Devices
Immunology
Drug Discovery
Clinical Trials
New Business Development
Commercialization
Pharmaceutical Sales
Licensing
Biochemistry
Market Access
Life Sciences
Copy Writing
Technology
Hans Christinger Summary
Hans Christinger, based in New York, NY, US, is currently a Chief Business Officer at Re-Vana Therapeutics. Hans Christinger brings experience from previous roles at NYBIO, Modig Life Sciences, Neurvati Neurosciences and KIF1A.ORG, INC.. Hans Christinger holds a 2000 - 2002 Master of Business Administration @ Babson College. With a robust skill set that includes Drug Development, Pharmaceutical Industry, Biotechnology, Lifesciences, Drug Delivery and more. Hans Christinger has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Hans Christinger?
Find contact details for 700 million professionals.